Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" OR cast your ballot here: https://app.propfuel.com/checkin/embed/0134a829-044f-4013-9a86-9673a398e121

Multidisciplinary Clinical Science Committee

The Multidisciplinary Clinical Science Committee at the IASLC comprises leading experts and researchers in the field of clinical thoracic oncology who will tackle key scientific questions in the diagnosis, treatment, and management of thoracic malignancies worldwide.
Multidisciplinary Clinical Science Committee

Committee Responsibilities:  

  1. Identify and prioritize research areas and topics of significant clinical relevance in thoracic malignancies.  
  2. Promote collaboration and knowledge exchange among researchers and institutions globally.  
  3. Encourage the development of innovative research methodologies and approaches to improve clinical outcomes.  
  4. Foster partnerships to support research initiatives.  
  5. Promote patient recruitment and engagement in clinical trials through educational campaigns and advocacy.  
  6. Encourage data sharing and collaboration among researchers to enhance statistical power and derive meaningful insights.  
  7. Promote the utilization of advanced analytics and artificial intelligence techniques for data analysis.  
  8. Organize scientific meetings, symposia, and workshops to disseminate the latest research findings and advancements in thoracic oncology.  
  9. Develop educational resources, guidelines, and position papers to guide clinical practice and inform healthcare professionals, patients, and the public.  
  10. Collaborate with other IASLC committees and external organizations to deliver comprehensive educational programs and materials.  
  11. Foster mentorship programs to support early-career researchers and clinicians in the field of thoracic malignancies. 
Mission

The Clinical Science Committee plays a pivotal role in advancing the field through its research initiatives, education, and advocacy efforts. By fostering collaboration and innovation, the committee aims to improve patient outcomes, enhance the quality of care, and contribute to the eradication of thoracic malignancies worldwide.

Chair of Committee

Tom Stinchcombe
Tom Stinchcombe
2023 - Present

Committee projects

Expert Panel & Consensus Statement: Defining Multidisciplinary Care for Thoracic Cancers

This project aims to provide an expert consensus definition of multidisciplinary care by evaluating differences in the composition of multidisciplinary teams, the time taken for evaluation by a multidisciplinary team, and the barriers to providing multidisciplinary care across various institutions, regions, or settings. The first phase of the project will involve a guidelines and literature review addressing multidisciplinary care.

Decision-Making Analysis & Manuscript: Understanding treatment Decisions & Discrepancies in Stage III NSCLC Care for Borderline Resectable Disease

One of the first initiatives of the Multidisciplinary Clinical Science Committee is to utilize objective consensus methodology among a group of multidisciplinary experts to identify overlaps or discrepancies in decision-making criteria, treatment options, and treatment decisions for Stage III NSCLC. This approach aims to pinpoint meaningful divergences in the decision-making process, which will be reported in a manuscript and will inform areas of focus for future projects.

Synoptic Procedural Reporting for Quality Assessment in Systematic Staging EBUS in NSCLC

Systematic staging is recommended for patients with clinical stage I-III NSCLC. This project seeks to establish standards for and implement synoptic reporting for systematic lymph node staging using endobronchial ultrasound (EBUS). The implementation of these standards will improve the quality of systematic lymph node staging where recommended, aiming to reduce variance in care and enhance the quality of EBUS staging.

2024 Radiation Oncology Webinar

The purpose of the webinar is to provide an annual update on new developments in Radiation Oncology within the increasingly multidisciplinary care for all stages and types of lung cancers. Highlights will include impactful studies from the recent ELCC and ESTRO scientific meetings, as well as new practice-changing radiation publications. As radiation continues to play a crucial role in the treatment of all stages and subtypes of lung cancer, this webinar aims to address some of the gaps for both radiation and non-radiation oncology healthcare professionals.

2023-2025 Roster

Tom Stinchcombe
United States
Duke Cancer Institute
Committee Chair
Tracy Leong
Australia
Austin Health
Deputy Chair
Natasha Leighl
Canada
Princess Margaret Hospital
Board Liaison
Kendra Lechtenberg
United States
International Association for the Study of Lung Cancer
Staff Liaison
Fernando Abrao
Brazil
Hospital Alemao Oswaldo Cruz
Committee Member
Guntulu Ak
Turkey
Eskisehir Osmangazi University Medical Faculty
Committee Member
Mara Antonoff
United States
The University of Texas MD Anderson Cancer Center
Committee Member
Houda Bahig
Canada
Centre Hospitalier de l'Université de Montréal
Committee Member
Tithi Biswas
United States
Case Medical Center, Seidman Cancer Center
Committee Member
Shamus Carr
United States
National Institutes of Health
Committee Member
Nicole Carriel
Chile
Clinica Santa Maria
Committee Member
Gilberto Castro Junior
Brazil
ICESP
Committee Member
Xiaohui Chen
China
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
Committee Member
Stephen Chun
United States
MD Anderson Cancer Center
Committee Member
Alissa Cooper
United States
Memorial Sloan Kettering Cancer Center
Committee Member
Luis Corrales-Rodriguez
Costa Rica
CCSS-ICOT-Clinica Biblica
Member
Corinne Faivre-Finn
United Kingdom
The Christie NHS Foundation Trust
Committee Chair
Wentao Fang
China
Shanghai Chest Hospital
Committee Member
Andrea Filippi
Italy
University of Milan and Istituto Nazionale Tumori, Milan
Committee Member
Pier Luigi Filosso
Italy
University of Torino
Committee Member
Florian Fintelmann
United States
Massachusetts General Hospital
Committee Member
Bailey Fitzgerald
United States
Roswell Park Comprehensive Cancer Center
Committee Member
Ken Harada
Japan
Showa University Northern Hospital, Yokohama
Committee Member
Long Jiang
China
Shanghai Chest Hospital
Committee Member
Julia Judd
United States
Fox Chase Cancer Center
Committee Member
Jin-Hyoung Kang
Republic of Korea
Catholic University of Korea Seoul St.Mary's Hospital
Committee Member
Jin Kang
China
Guangdong Lung Cancer Institute
Committee Member
Divya Khosla
India
Postgraduate Institute of Medical Education and Research (PGIMER)
Committee Member
Feng-Ming Spring Kong
China
The University of Hong Kong
Committee Member
Milica Kontic Jovanovic
Serbia
University Clinical Centre of Serbia
Committee Member
Vincent Lam
United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Committee Member
Xiuning Le
United States
The University of Texas MD Anderson Cancer Center
Committee Member
Pyng Lee
Singapore
National University Heatlth System
Committee Member
David Lee
Malaysia
University of Malaya
Committee Member
Hecheng Li
China
Ruijin Hospital
Committee Member
Alexander Louie
Canada
Sunnybrook Health Sciences Centre
Committee Member
Kristen Marrone
United States
Johns Hopkins University School of Medicine
Committee Member
Clarissa Mathias
Brazil
Nucleo de Oncologia da Bahia
Committee Member
Fiona McDonald
United Kingdom
The Royal Marsden Hospital
Committee Chair
Vanessa Menezes
Canada
University of Toronto
Committee Member
Pablo Munoz Schuffenegger
Chile
Pontificia Universidad Católica de Chile
Committee Member
Thomas Newsom-Davis
United Kingdom
Chelsea and Westminster Hospital
Committee Member
Sandip Patel
United States
UCSD Moores Cancer Center
Committee Member
Daniel Przybysz
Brazil
UpToDate Oncology, RadioSerra Radiation Oncology
Committee Member
Paul Martin Putora
Switzerland
Kantonsspital St. Gallen
Committee Member
Angel Qin
United States
University of Michigan
Committee Member
Shankar Siva
Australia
Peter MacCallum Cancer Center
Committee Member
Xuqi Sun
China
The First Affiliated Hospital, Zhejiang University School of Medicine
Committee Member
Akif Turna
Turkey
Istanbul University Cerrahpasa Medical School
Committee Member
Vamsidhar Velcheti
United States
New York University School of Medicine
Committee Member
Luigi Ventura
United Kingdom
Sheffield Teaching Hospital NHS Foundation Trust
Committee Member
William Nassib William Jr.
Brazil
Grupo Oncoclínicas
Committee Member
Yang Xia
China
Second Affiliated Hospital of Zhejiang University School of Medicine
Committee Member
Nathan Yu
United States
Mayo Clinic
Committee Member
Jamal Zaini
Indonesia
University of Indonesia
Committee Member
Yang Zhang
China
Shanghai Chest Hospital
Committee Member
Hongcheng Zhu
China
Fudan University Shanghai Cancer Center
Committee Member

Committee Nominations are now closed.

New Committee Nominations will take place again in 2025.